Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Checler

Showing results (111-120 of 120) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 120 results.
Annals of Neurology|May 19, 1998
Neuropathology of preclinical and clinical late-onset Alzheimer's diseaseJ C Troncoso, A M Cataldo, R A Nixon, et al.
Cell Death and Differentiation|August 15, 2009
Loss of function of DJ-1 triggered by Parkinson's disease-associated mutation is due to proteolytic resistance to caspase-6E Giaime, C Sunyach, C Druon, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 11, 2000
Behavioral alterations associated with apoptosis and down-regulation of presenilin 1 in the brains of p53-deficient miceR Amson, J M Lassalle, H Halley, et al.
Biochemical and Biophysical Research Communications|September 15, 1998
Neuropeptide specificity and inhibition of recombinant isoforms of the endopeptidase 3.4.24.16 family: comparison with the related recombinant endopeptidase 3.4.24.15V Rioli, A Kato, F C Portaro, et al.
Journal of Neuroscience Research|November 5, 2003
JLK isocoumarin inhibitors: selective gamma-secretase inhibitors that do not interfere with notch pathway in vitro or in vivoA Petit, A Pasini, C Alves Da Costa, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 16, 1999
Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiencyA Herreman, D Hartmann, W Annaert, et al.
Molecular Medicine (Cambridge, Mass.)|December 10, 1997
Characterization of new polyclonal antibodies specific for 40 and 42 amino acid-long amyloid beta peptides: their use to examine the cell biology of presenilins and the immunohistochemistry of sporadic Alzheimer's disease and cerebral amyloid angiopathy casesH Barelli, A Lebeau, J Vizzavona, et al.
The American Journal of Pathology|October 6, 2000
Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the london mutant of human APP in neuronsJ Van Dorpe, L Smeijers, I Dewachter, et al.
Translational Psychiatry|July 18, 2013
Cerebrospinal Aβ11-x and 17-x levels as indicators of mild cognitive impairment and patients' stratification in Alzheimer's diseaseJ-D Abraham, S Promé, N Salvetat, et al.
Nature Medicine|April 18, 1998
Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptidesH Xu, G K Gouras, J P Greenfield, et al.
Pageof 12

Showing results (111-120 of 120) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
Annals of Neurology|May 19, 1998
Neuropathology of preclinical and clinical late-onset Alzheimer's diseaseJ C Troncoso, A M Cataldo, R A Nixon, et al.
Cell Death and Differentiation|August 15, 2009
Loss of function of DJ-1 triggered by Parkinson's disease-associated mutation is due to proteolytic resistance to caspase-6E Giaime, C Sunyach, C Druon, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 11, 2000
Behavioral alterations associated with apoptosis and down-regulation of presenilin 1 in the brains of p53-deficient miceR Amson, J M Lassalle, H Halley, et al.
Biochemical and Biophysical Research Communications|September 15, 1998
Neuropeptide specificity and inhibition of recombinant isoforms of the endopeptidase 3.4.24.16 family: comparison with the related recombinant endopeptidase 3.4.24.15V Rioli, A Kato, F C Portaro, et al.
Journal of Neuroscience Research|November 5, 2003
JLK isocoumarin inhibitors: selective gamma-secretase inhibitors that do not interfere with notch pathway in vitro or in vivoA Petit, A Pasini, C Alves Da Costa, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 16, 1999
Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiencyA Herreman, D Hartmann, W Annaert, et al.
Molecular Medicine (Cambridge, Mass.)|December 10, 1997
Characterization of new polyclonal antibodies specific for 40 and 42 amino acid-long amyloid beta peptides: their use to examine the cell biology of presenilins and the immunohistochemistry of sporadic Alzheimer's disease and cerebral amyloid angiopathy casesH Barelli, A Lebeau, J Vizzavona, et al.
The American Journal of Pathology|October 6, 2000
Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the london mutant of human APP in neuronsJ Van Dorpe, L Smeijers, I Dewachter, et al.
Translational Psychiatry|July 18, 2013
Cerebrospinal Aβ11-x and 17-x levels as indicators of mild cognitive impairment and patients' stratification in Alzheimer's diseaseJ-D Abraham, S Promé, N Salvetat, et al.
Nature Medicine|April 18, 1998
Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptidesH Xu, G K Gouras, J P Greenfield, et al.
Pageof 12